142 related articles for article (PubMed ID: 18076947)
1. The 20-core prostate biopsy protocol--a new gold standard?
Ravery V; Dominique S; Panhard X; Toublanc M; Boccon-Gibod L; Boccon-Gibod L
J Urol; 2008 Feb; 179(2):504-7. PubMed ID: 18076947
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS
J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
[TBL] [Abstract][Full Text] [Related]
3. Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors?
Chan TY; Chan DY; Stutzman KL; Epstein JI
J Urol; 2001 Dec; 166(6):2181-4. PubMed ID: 11696731
[TBL] [Abstract][Full Text] [Related]
4. Prediction of extraprostatic extension in the neurovascular bundle based on prostate needle biopsy pathology, serum prostate specific antigen and digital rectal examination.
Tsuzuki T; Hernandez DJ; Aydin H; Trock B; Walsh PC; Epstein JI
J Urol; 2005 Feb; 173(2):450-3. PubMed ID: 15643200
[TBL] [Abstract][Full Text] [Related]
5. Patients with low prostate-specific antigen levels (< or =4 ng/ml) would benefit from a twelve-core biopsy protocol for prostate cancer detection.
Thiesler T; Trinkler F; Horcic M; Willi N; Cathomas G; Hailemariam S
Urol Int; 2007; 78(4):318-22. PubMed ID: 17495489
[TBL] [Abstract][Full Text] [Related]
6. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
Capitanio U; Karakiewicz PI; Valiquette L; Perrotte P; Jeldres C; Briganti A; Gallina A; Suardi N; Cestari A; Guazzoni G; Salonia A; Montorsi F
Urology; 2009 May; 73(5):1087-91. PubMed ID: 19195695
[TBL] [Abstract][Full Text] [Related]
7. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection.
Eskicorapci SY; Guliyev F; Akdogan B; Dogan HS; Ergen A; Ozen H
J Urol; 2005 May; 173(5):1536-40. PubMed ID: 15821481
[TBL] [Abstract][Full Text] [Related]
8. The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management.
Ochiai A; Troncoso P; Chen ME; Lloreta J; Babaian RJ
J Urol; 2005 Dec; 174(6):2164-8, discussion 2168. PubMed ID: 16280756
[TBL] [Abstract][Full Text] [Related]
9. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.
Chiang IN; Chang SJ; Pu YS; Huang KH; Yu HJ; Huang CY
Urol Int; 2009; 82(3):270-5. PubMed ID: 19440012
[TBL] [Abstract][Full Text] [Related]
11. Initial extended transrectal prostate biopsy--are more prostate cancers detected with 18 cores than with 12 cores?
Scattoni V; Roscigno M; Raber M; Dehò F; Maga T; Zanoni M; Riva M; Sangalli M; Nava L; Mazzoccoli B; Freschi M; Guazzoni G; Rigatti P; Montorsi F
J Urol; 2008 Apr; 179(4):1327-31; discussion 1331. PubMed ID: 18289580
[TBL] [Abstract][Full Text] [Related]
12. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.
Guichard G; Larré S; Gallina A; Lazar A; Faucon H; Chemama S; Allory Y; Patard JJ; Vordos D; Hoznek A; Yiou R; Salomon L; Abbou CC; de la Taille A
Eur Urol; 2007 Aug; 52(2):430-5. PubMed ID: 17412489
[TBL] [Abstract][Full Text] [Related]
13. Role of transperineal six-core prostate biopsy in patients with prostate-specific antigen level greater than 10 ng/mL and abnormal digital rectal examination findings.
Luciani LG; De Giorgi G; Valotto C; Zanin M; Bierti S; Zattoni F
Urology; 2006 Mar; 67(3):555-8. PubMed ID: 16527579
[TBL] [Abstract][Full Text] [Related]
14. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H
Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653
[TBL] [Abstract][Full Text] [Related]
15. Indications for preoperative prostate biopsy in patients undergoing radical cystoprostatectomy for bladder cancer.
Thomas C; Wiesner C; Melchior S; Gillitzer R; Schmidt F; Thüroff JW
J Urol; 2008 Nov; 180(5):1938-41; discussion 1941. PubMed ID: 18801501
[TBL] [Abstract][Full Text] [Related]
16. Optimizing prostate cancer detection: 8 versus 12-core biopsy protocol.
de la Rosette JJ; Wink MH; Mamoulakis C; Wondergem N; ten Kate FJ; Zwinderman K; de Reijke TM; Wijkstra H
J Urol; 2009 Oct; 182(4):1329-36. PubMed ID: 19683269
[TBL] [Abstract][Full Text] [Related]
17. A single microfocus (5% or less) of Gleason 6 prostate cancer at biopsy--can we predict adverse pathological outcomes?
Thong AE; Shikanov S; Katz MH; Gofrit ON; Eggener S; Zagaja GP; Shalhav AL; Zorn KC
J Urol; 2008 Dec; 180(6):2436-40. PubMed ID: 18930486
[TBL] [Abstract][Full Text] [Related]
18. Value of real-time elastography targeted biopsy for prostate cancer detection in men with prostate specific antigen 1.25 ng/ml or greater and 4.00 ng/ml or less.
Aigner F; Pallwein L; Junker D; Schäfer G; Mikuz G; Pedross F; Mitterberger MJ; Jaschke W; Halpern EJ; Frauscher F
J Urol; 2010 Sep; 184(3):913-7. PubMed ID: 20643432
[TBL] [Abstract][Full Text] [Related]
19. Prediction of extracapsular extension of prostate cancer based on systematic core biopsies.
Tarján M; Tot T
Scand J Urol Nephrol; 2006; 40(6):459-64. PubMed ID: 17130097
[TBL] [Abstract][Full Text] [Related]
20. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]